In our latest Sustainability Report from the European Equities team, we take a closer look at two portfolio holdings at the cutting edge of healthcare innovation and discuss how they are helping to support efforts to end epidemics and reduce the mortality rate of non-communicable diseases.
Key Points:
- Overview of the objectives of SDG 3
- Sustainable Europe and Sustainable Europe ex-UK: SDG alignment, engagement progress and environmental highlights
- Case study: Novo Nordisk
- Case study: Lonza Group
European Equities Sustainability Report, H1 2022
Share:
